In Brief: Oncor
This article was originally published in The Gray Sheet
Executive Summary
Oncor: Acquires exclusive worldwide license from Johns Hopkins University for technology that will detect "small numbers of metastatic cancer cells in surgical sections and lymph nodes." Initially to be commercialized through Oncor's medical services affiliate, OncorMed, the technology will be used to test tissue adjacent to tumor sites for remaining genetic mutations after the tumor has been removed...